However, researchers have found that the “normal” PSA level of 0–4 ng/mL does not guarantee cancer-free status; in approximately 25% of men with a PSA below 4 ng/mL, a biopsy still reveals PCa (Kitagawa et al., 2014). This evidence concerns the gene KLK3 and posterior cortical atrophy.